뒤로
Marvel Biosciences Corp (MBCOF) 수입
MBCOF 주가 차트
MBCOF 수입
Marvel Biosciences Corp
$0.11
0%
$0
종가: Mar 27, 16:00:00 GMT-4
$0.11
0%
$0
애프터마켓: Mar 27, 20:00:00 GMT-4
Earnings FAQ
MBCOF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Marvel Biosciences Corp MBCOF의 지난 분기 매출 실적은 어땠나요?
Marvel Biosciences Corp의 매출 추정치는 얼마인가요?
Marvel Biosciences Corp의 수익 품질 점수는 얼마인가요?
Marvel Biosciences Corp는 언제 수익을 보고하나요?
Marvel Biosciences Corp의 예상 수익은 얼마인가요?
Marvel Biosciences Corp은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.11
시가
$0.11
일일 범위
$0.11 - $0.1121
52주 범위
$0.046 - $0.241
거래량
--
평균 거래량
12.8K
배당수익률
--
EPS(TTM)
-0.04
시가총액
$6.9M
MARVEL BIOSCIENCES CORP.란 무엇인가요?
Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-02-28. The firm develops new synthetic chemical derivatives of the original approved drug for the new disease indication. The company has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The firm's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The firm is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.